Found variations in health-related quality of life based on tumor site.
Observed significant differences in symptom burden related to disease duration.
Emphasized the importance of longitudinal assessments for improving patient care.
Abstract
This large U.S. cohort reveals persistent symptom burden and HRQoL variation by tumor site and disease duration, underscoring the need for longitudinal HRQoL assessment in NET care.